CDC Vaccine Panel Gets New Members Again, With A Skeptic In Lead

The U.S. vaccine advisory landscape is facing a seismic shift as Health Secretary Robert F. Kennedy Jr. moves to reshape the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP). According to an internal CDC document reviewed by Reuters, Kennedy has nominated seven new members to the ACIP, following his controversial ousting of all 17 previous panelists in June. The move has drawn scrutiny from public health experts who fear that vaccine guidance could be increasingly influenced by political considerations rather than scientific consensus.The ACIP has long been a cornerstone of U.S. vaccine policy, advising the CDC on which vaccines should be administered, to whom, and on what schedule after Food and Drug Administration (FDA) approval. The committee’s recommendations form the basis for insurance coverage across the country and are integral to maintaining herd immunity and public trust in vaccines. Kennedy’s decision to fire all 17 members mid-year and replace them with a hand-picked cohort of eight advisers — one of whom has since left — marks an unprecedented intervention in the advisory process.Among the seven prospective members named in the latest internal document is Dr. Raymond Pollak, a semi-retired transplant surgeon with a background in immunology. Pollak confirmed that he has been asked to serve on the panel but remains cautious. “I’m being considered pending the vetting process. If I was offered the position, I would think carefully about it,” he told reporters.Other appointees include Dr. Joseph Fraiman, an emergency medicine specialist in New Orleans; Dr. John Gaitanis, a pediatric neurologist; Dr. Catherine Stein, an epidemiology professor; Hillary Blackburn, a trained pharmacist; and Evelyn Griffin, an obstetrician-gynecologist. None of these professionals were immediately available for comment. Retsef Levi, PhD, will chair the newly restructured COVID-19 Immunization Workgroup, drawing particular concern from infectious disease specialists.What Are The Concerns Over Panel Independence?The rapid overhaul of ACIP has sparked widespread debate about the independence and credibility of the panel. Critics argue that Kennedy, a long-standing vaccine skeptic, has moved to stack the committee with individuals whose views align with his own. The firing of CDC Director Susan Monarez last week further amplified these concerns. Monarez reportedly resisted policy changes advanced by Kennedy and was asked to merely rubber-stamp committee recommendations. Her departure prompted resignations from three top CDC officials, citing the secretary’s anti-vaccine policies as their reason.Does This Pull The Stakes Down For Vaccine Policy in US?The ACIP is scheduled to meet on September 18, with discussions likely to include recommendations for hepatitis B, measles-mumps-rubella-varicella, and respiratory syncytial virus (RSV) vaccines, according to the Federal Register. Traditionally, the CDC director holds final approval over these recommendations. With the new panel in place, public health experts worry that guidance on critical vaccines — including COVID-19 immunizations — could diverge from established scientific evidence, potentially affecting millions of Americans.Levi, who will lead the COVID-19 Immunization Workgroup, has previously expressed skepticism about mRNA COVID vaccines. In a 2023 video posted on social media, he asserted that all COVID mRNA vaccination programs “should stop immediately,” claiming that they failed to deliver on efficacy promises and caused “unprecedented levels of harm, including the death of young people and children.” Such statements have alarmed epidemiologists and infectious disease specialists, who warn that this rhetoric could erode public trust in vaccines and heighten vulnerability to preventable diseases.Implications for Public Health and Vaccine UptakePublic health experts emphasize that vaccine recommendations are not merely technical decisions; they have real-world consequences for community immunity, disease outbreaks, and healthcare costs. The credibility of ACIP is pivotal in maintaining high vaccination rates, especially for routine childhood immunizations and COVID-19 boosters. Should the panel’s guidance shift toward skepticism of established vaccines, experts fear a rise in vaccine hesitancy, lower immunization coverage, and a resurgence of preventable diseases.Insurance coverage is closely tied to ACIP recommendations. Altering the panel’s guidance could potentially influence which vaccines are covered by public and private insurers, affecting accessibility and uptake. Given the ongoing threat of seasonal influenza, RSV, and COVID-19, changes to vaccine policy may have profound implications for hospitalizations, morbidity, and mortality, particularly among vulnerable populations such as children, the elderly, and immunocompromised individuals.Is There Too Much Political Interference in Health Policy-Making?Kennedy’s actions are part of a broader national debate on the role of politics in public health. While previous ACIP appointments have been largely insulated from political influence, recent interventions signal a shift toward a more politicized approach to vaccine policy. Experts caution that such moves could undermine decades of public trust in the CDC, an institution that has long been regarded as the gold standard in epidemiology and disease prevention.The revamp of ACIP also underscores tensions within the CDC and the U.S. Department of Health and Human Services (HHS). Multiple top officials have resigned or been replaced in recent months, raising questions about institutional stability and the agency’s ability to respond effectively to public health crises.The upcoming ACIP meeting on September 18 will be closely monitored by public health officials, epidemiologists, and the media. Key topics likely to be addressed include routine childhood vaccines, COVID-19 booster policies, and emerging infectious diseases such as RSV. Observers will be watching not just the committee’s recommendations but also the process by which they are finalized and approved.Experts urge the public to remain vigilant and informed about vaccine guidance, noting that evidence-based practices remain critical for preventing disease outbreaks and safeguarding community health. While the political dynamics are evolving, the scientific principles underpinning immunization safety, efficacy, and population protection continue to be essential in maintaining public health.Robert F. Kennedy Jr.’s appointment of seven new members to the CDC’s ACIP marks a turning point in U.S. vaccine policy. The unprecedented shake-up raises questions about the independence, credibility, and scientific rigor of the nation’s primary vaccine advisory body. With critical vaccine recommendations on the horizon, public health experts, policymakers, and citizens alike are bracing for the potential ramifications of a panel reshaped under political influence, highlighting the fragile balance between science and governance in safeguarding public health.

CDC Vaccine Panel Gets New Members Again, With A Skeptic In Lead

Quick Stories

NHS Says Martha’s Rule To be Followed At All Hospitals In England: All About This New Rule?

World Sexual Health Day 2025: Theme, Significance And What You Can Do To Make Sexual Wellness Everyday Health

Florida Aims To End All Vaccine Mandates, Says State's Surgeon General Joseph Ladapo

Health Conditions A-Z

CDC Vaccine Panel Gets New Members Again, With A Skeptic In Lead

NHS Says Martha’s Rule To be Followed At All Hospitals In England: All About This New Rule?

COVID Symptoms Are Different In 2025—How Long After Exposure Should You Get Tested?